Amgen

First 'biosimilar' drug launches in the US, years after other countries
Yahoo/AP
Thu, 09/10/15 - 06:04 pm
biosimilars
Sandoz
Zarxio
Neupogen
Amgen
Independent group finds new cholesterol drugs far too costly
Yahoo/Reuters
Wed, 09/9/15 - 10:12 pm
drug pricing
PCSK9 inhibitors
Praluent
Repatha
Amgen
Sanofi
Regeneron
Merck and Samsung notch their first biosimilar victory with Enbrel knockoff
Fierce Biotech
Wed, 09/9/15 - 10:42 am
Merck
Samsung Bioepis
Enbrel
biosimilars
Amgen
rheumatoid arthritis
What’s the Market Response to Repatha’s Approval?
Yahoo/Market Realist
Tue, 09/8/15 - 08:03 am
Repatha
Amgen
PCSK9 inhibitors
PCSK9 Inhibitor Therapies Face Pricing Pressures
Yahoo/Market Realist
Mon, 09/7/15 - 11:45 am
PCSK9 inhibitors
drug pricing
Praluent
Repatha
Amgen
Regeneron
Sanofi
Biotech Blue-Chip Amgen Took a Drubbing Last Month -- Here's Why
Motley Fool
Mon, 09/7/15 - 11:36 am
Amgen
Amgen: Time is on My Side
Barron's
Sat, 09/5/15 - 10:56 am
Amgen
Coherus Biosciences
FDA
Neulasta
Apotex
Sandoz: Zarxio marketing to be similar to a branded-drug launch
Fierce Pharma Marketing
Thu, 09/3/15 - 06:46 pm
Sandoz
Zarxio
biosimilars
Novartis
drug launches
Amgen
Neupogen
Amgen swings for EU approval with its new kidney drug
Fierce Biotech
Thu, 09/3/15 - 11:47 am
Amgen
Europe
kidney dialysis
etelcalcetide
Novartis launches first U.S. 'biosimilar' drug at 15 pct discount
Yahoo/Reuters
Thu, 09/3/15 - 08:45 am
Novartis
biosimilars
Amgen
Neupogen
Zarxio
Sandoz
Amgen Inc.'s FDA Approval Holds Blockbuster Potential
Motley Fool
Thu, 09/3/15 - 08:44 am
Amgen
FDA
Repatha
Amgen cannot stop imminent sale of Neupogen copycat: US appeals court
Yahoo/Reuters
Wed, 09/2/15 - 12:37 pm
Amgen
Neupogen
biosimilars
Zarxio
Novartis
Sandoz
2 major insurers draw lines in the sand for pricey PCSK9 coverage
BioPharma Dive
Wed, 09/2/15 - 12:34 pm
PCSK9 inhibitors
insurers
Regeneron
Sanofi
Amgen
Praluent
Repatha
Novartis to Work With Amgen on Alzheimer’s and Migraine Drugs
Bloomberg
Wed, 09/2/15 - 10:18 am
Novartis
Amgen
migraines
Alzheimer's disease
R&D
CNP520
AMG 334
Amgen's bone drug succeeds in late-stage study
Yahoo/Reuters
Tue, 09/1/15 - 06:40 pm
Amgen
osteoporosis
romosozumab
Amgen Finds Data Falsified in Obesity-Diabetes Study Featuring Grizzly Bears
WSJ Online
Tue, 09/1/15 - 06:34 pm
Amgen
diabetes
obesity
Approval Of Repatha May Give Amgen A $5B Boost
Seeking Alpha
Mon, 08/31/15 - 05:28 pm
Repatha
Amgen
PCSK9 inhibitors
Praluent
Sanofi
Regeneron
Amgen, Inc. Or Regeneron Pharmaceuticals Inc - Who Would Win The PCSK-9 Race?
Bidness, ETC
Mon, 08/31/15 - 11:13 am
PCSK9 inhibitors
Amgen
Regeneron
Repatha
Praluent
​Trial suggests Alnylam's cholesterol-lowering drug may last longer than Amgen's
Bizjournals.com
Sun, 08/30/15 - 02:04 pm
Alnylam
Amgen
The Medicines Company
PCSK9 inhibitors
ALN-PCSsc
Repatha
Praluent
Gilead & Amgen Account for Nearly 75% of the Biotech Profit Pool
Barron's
Sat, 08/29/15 - 09:03 am
Gilead Sciences
Amgen
biotech

Pages